BioE3 Policy to support biomanufacturing facilities
There are a billion reasons to invest in India for the country has the 2nd highest number of USFDA approved manufacturing plants outside the USA, and opportunities for investments are available in Bio-Pharma, Bio-Agri, Bio-Industrial, Bio-energy, Bio-Services and Med-Tech.
This was stated by Minister of State for Science and Technology Dr Jitendra Singh at the inaugural ceremony of Global Bio India 2024 in Delhi on 12 Sept.
Underscoring that “Bio-revolution” in India synonymous to the IT Revolution driven by the western world, Dr Singh categorically mentioned the recently approved BioE3 (Biotechnology for Economy, Employment, and Environment) Policy.
The BioE3 Policy will support this establishment of cutting-edge biomanufacturing facilities, bio foundry clusters, and Bio-AI hubs, he elaborated.
The biotech hubs will bridge the gap between research and commercial manufacturing, fostering collaboration between startups, SMEs, and established companies, thereby, boosting High performance Biomanufacturing and Bioeconomy. Integration of AI to analyze large-scale biological data, will pave the way for advancements in gene therapies, food processing added the minister.
“It is a timely intervention at this crucial juncture for our country in the back drop of global climate change to enable creation of a cleaner, greener and prosperous India,” he said, expressing confidence that the new policy would contribute significantly to the global economy while protecting our environment.
He also reiterated the key areas of focus such as bio-based chemicals and enzymes, smart proteins, precision biotherapeutics, climate-resilient agriculture, carbon capture and utilization, and advanced marine and space research.
Dr Singh referred to these as the future of biotechnology and drive growth and innovation across various industries.
He also emphasizing on the employment opportunities being created, particularly in tier-II and tier-III cities he stated that biomanufacturing hubs will use local resources and contribute to regional economic development, promoting more inclusive growth.
The Biotechnology Industry Research Assistance Council (BIRAC) has signed Letters of Intent at the conference with 9 leading international organisations in Biotechnology.
These are:
- United States Pharmacopeial Convention (USP);
- UK Research and Innovation (UKRI), UK;
- DHR Holding India Pvt Ltd (Danaher);
- Mauritius Institute of Biotechnology Ltd (MIBL);
- La Trobe University;
- Blockchain for Impact (BFI);
- US-India Strategic Partnership Forum (USISPF);
- IBioM (Indian Biotech MSME and Startup Foundation);
- Bharat Startup and Innovation Society (BSIS)- Bharat Startup Festival. Fiinews.com
